Tentative Biosimilar Approvals A Consideration for the US FDA

 
• By Derrick Gingery
  
Syringe in vial
The FDA is working on several other biosimilar policy areas, including labeling and interchangeability. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics